Several embodiments of the present disclosure relate to glycotargeting therapeutics that are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.
57730362
56692928
53762221
57121450
Alternative title(s) : (de) Glyco-targetierende therapeutika (fr) Agents thérapeutiques de glycociblage
TTO:6.1372
Patent number | Country code | Kind code | Date issued |
EP4385520 | EP | A2 | 2024-06-19 |
JP2024063005 | JP | A | 2024-05-10 |
CN108430497 | CN | B | 2024-05-07 |
JP2024037920 | JP | A | 2024-03-19 |
JP7434248 | JP | B2 | 2024-02-20 |
IL257958 | IL | B2 | 2024-02-01 |
IL306015 | IL | A | 2023-11-01 |
US11801305 | US | B2 | 2023-10-31 |
US11793882 | US | B2 | 2023-10-24 |
IL257958 | IL | B1 | 2023-10-01 |
CA2946064 | CA | C | 2023-09-26 |
AU2023203475 | AU | A1 | 2023-06-29 |
US11666638 | US | B2 | 2023-06-06 |
IL283100 | IL | B2 | 2023-06-01 |
US11654188 | US | B2 | 2023-05-23 |
US2023119325 | US | A1 | 2023-04-20 |
US2023115331 | US | A1 | 2023-04-13 |
US2023108299 | US | A1 | 2023-04-06 |
US2023093483 | US | A1 | 2023-03-23 |
AU2016325073 | AU | B2 | 2023-03-16 |
KR20230003288 | KR | A | 2023-01-05 |
JP7082045 | JP | B2 | 2022-06-07 |
JP2022070910 | JP | A | 2022-05-13 |
JP2022028673 | JP | A | 2022-02-16 |
MX2021012636 | MX | A | 2022-01-04 |
EP3909603 | EP | A1 | 2021-11-17 |
ES2874884 | ES | T3 | 2021-11-05 |
LT3107563 | LT | T | 2021-07-12 |
IL283100 | IL | A | 2021-06-30 |
IL247283 | IL | B | 2021-05-31 |
DK3107563 | DK | T3 | 2021-05-25 |
EP3107563 | EP | B1 | 2021-04-07 |
AU2021201504 | AU | A1 | 2021-03-25 |
US10953101 | US | B2 | 2021-03-23 |
US10946079 | US | B2 | 2021-03-16 |
US10940209 | US | B2 | 2021-03-09 |
SG10202010936R | SG | A | 2020-12-30 |
EA036102 | EA | B9 | 2020-12-30 |
AU2015233084 | AU | B2 | 2020-12-17 |
US10821157 | US | B2 | 2020-11-03 |
EA036102 | EA | B1 | 2020-09-29 |
JP6744227 | JP | B2 | 2020-08-19 |
JP2020121981 | JP | A | 2020-08-13 |
US2020129629 | US | A1 | 2020-04-30 |
US2020129601 | US | A1 | 2020-04-30 |
US2020129625 | US | A1 | 2020-04-30 |
US2020121762 | US | A1 | 2020-04-23 |
HK1257845 | HK | A1 | 2019-11-01 |
JP2018532722 | JP | A | 2018-11-08 |
US2018303951 | US | A1 | 2018-10-25 |
BR112018005409 | BR | A2 | 2018-10-09 |
US2018271986 | US | A1 | 2018-09-27 |
MX2018003411 | MX | A | 2018-09-06 |
EA201890778 | EA | A1 | 2018-08-31 |
CN108430497 | CN | A | 2018-08-21 |
US10046056 | US | B2 | 2018-08-14 |
EP3349784 | EP | A1 | 2018-07-25 |
KR20180080195 | KR | A | 2018-07-11 |
IL257958 | IL | A | 2018-06-28 |
AU2016325073 | AU | A1 | 2018-04-05 |
NZ723879 | NZ | A | 2018-03-23 |
HK1232151 | HK | A1 | 2018-01-05 |
US2017296636 | US | A9 | 2017-10-19 |
BR112016019274 | BR | A2 | 2017-10-10 |
MX2016010835 | MX | A | 2017-07-11 |
EA201691686 | EA | A1 | 2017-03-31 |
CA2998066 | CA | A1 | 2017-03-23 |
WO2017046652 | WO | A1 | 2017-03-23 |
JP2017507180 | JP | A | 2017-03-16 |
CN106456743 | CN | A | 2017-02-22 |
US2017007708 | US | A1 | 2017-01-12 |
EP3107563 | EP | A2 | 2016-12-28 |
KR20160135214 | KR | A | 2016-11-25 |
SG11201606761R | SG | A | 2016-09-29 |
AU2015233084 | AU | A1 | 2016-09-08 |
US2016243248 | US | A1 | 2016-08-25 |
US2016015821 | US | A1 | 2016-01-21 |
WO2015140648 | WO | A3 | 2016-01-14 |
CA2946064 | CA | A1 | 2015-09-24 |
WO2015140648 | WO | A2 | 2015-09-24 |